Trial Profile
Bioequivalence Study Comparing Two Salmeterol/Fluticasone Propionate Dry Powder Inhalers, SF Easyhaler and Seretide Diskus 50/500 Mcg/Inhalation; Randomised, Double-blind, Single Centre, Single Dose, Crossover Study in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2014
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Charcoal
- Indications Asthma; Chronic obstructive pulmonary disease; Rhinitis
- Focus Pharmacokinetics
- Sponsors Orion Pharma
- 16 Jan 2014 Status changed from recruiting to completed as per ClinicalTrials.gov.
- 24 Jan 2013 New trial record